Stock listing

NASDAQ:TOCA Tocagen Inc Stock

Follow Tocagen Inc into a list and get an email when it puts out news.

Delisted NASDAQ:TOCA no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:TOCA
Asset type
Stock
Exchange
NASDAQ
Currency
USD

What changed lately

Tocagen Inc on 6ix

Decks
23 decks · latest Jul 9, 2026

Decks

DeckKindSlidesDate
Forte Biosciences — Technical Presentation (July 2026)Technical21 slidesJul 9, 2026
Forte Biosciences — Corporate Update (August 2025)Corporate update68 slidesAug 14, 2025
Forte Biosciences — Technical Presentation (June 2025)Technical33 slidesJun 23, 2025
Forte Biosciences — Investor Presentation (June 2025)Investor deck66 slidesJun 23, 2025
Forte Biosciences — Investor Presentation (December 2024)Investor deck60 slidesDec 3, 2024
Forte Biosciences — Investor Presentation (December 2024)Investor deck49 slidesDec 3, 2024
Forte Biosciences — Investor Presentation (August 2024)Investor deck46 slidesAug 14, 2024
Forte Biosciences — Investor Presentation (May 2024)Investor deck32 slidesMay 13, 2024
Forte Biosciences — Investor Presentation (March 2024)Investor deck32 slidesMar 18, 2024
Forte Biosciences — Proxy Contest (September 2023)Proxy contest40 slidesSep 1, 2023
All 23 decks
DeckKindSlidesDate
Forte Biosciences — Proxy Contest (August 2023)Proxy contest23 slidesAug 31, 2023
Forte Biosciences — Investor Presentation (August 2023)Investor deck34 slidesAug 1, 2023
Forte Biosciences — Investor Presentation (August 2022)Investor deck13 slidesAug 15, 2022
Forte Biosciences — Investor Presentation (May 2022)Investor deck12 slidesMay 16, 2022
Forte Biosciences — Investor Presentation (May 2021)Investor deck30 slidesMay 10, 2021
Forte Biosciences — Investor Presentation (March 2021)Investor deck30 slidesMar 24, 2021
Forte Biosciences — Investor Presentation (November 2020)Investor deck30 slidesNov 10, 2020
Forte Biosciences — Investor Presentation (September 2020)Investor deck30 slidesSep 9, 2020
Forte Biosciences — Investor Presentation (June 2020)Investor deck17 slidesJun 26, 2020
Merger or Acquisition (February 2020)Merger or acquisition19 slidesFeb 20, 2020
Corporate Update (November 2019)Corporate update31 slidesNov 22, 2019
Investor Presentation (December 2018)Investor deck38 slidesDec 12, 2018
Investor Presentation (October 2018)Investor deck38 slidesOct 9, 2018

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Faheem Hasnain
Other companies: Aspen Neuroscience, Inc. (Aspen Executive Chairman · Since at least Nov 2, 2026); Gossamer Bio, Inc. (Co-Founder, Chairman, and Chief Executive Officer · Since at least Feb 7, 2019); Kura Oncology, Inc. (Lead Independent Director · Since at least Apr 23, 2015); Nuvation Bio Inc. (Director · Jun 30, 2020 – Feb 10, 2021 · Past); Immunic, Inc. (Director · Aug 11, 2016 – Sep 13, 2018 · Past); Ambit Biosciences Corp (Director · May 15, 2013 – Nov 10, 2014 · Past); Receptos Inc (President & CEO, Director · May 8, 2013 – Aug 25, 2015 · Past); Somaxon Pharmaceuticals Inc (Director · Sep 16, 2010 – Dec 31, 2012 · Past); Facet Biotech Corp (President & CEO, Director · Dec 9, 2008 – Apr 21, 2010 · Past); PDL BioPharma Inc (President & CEO, Director · Oct 1, 2008 – Oct 1, 2008 · Past)
Director · Apr 12, 2017 – Oct 4, 2019 · Past
Franklin Berger
Other companies: Retension Pharmaceuticals, Inc. (Director · Since at least Oct 13, 2026); Atea Pharmaceuticals, Inc. (Director · Since at least Oct 29, 2020); ESSA Pharma Inc (Director · Since at least Oct 1, 2020); Kezar Life Sciences, Inc. (Director · Since at least Jun 25, 2019); Rain Oncology Inc (Director · Apr 22, 2021 – Jan 26, 2024 · Past); Kineta Inc. (Director · Jun 27, 2019 – Jun 29, 2020 · Past); Atreca Inc (Director · Jun 19, 2019 – Jun 13, 2023 · Past); Five Prime Therapeutics Inc (Director · Jun 10, 2019 – Apr 16, 2021 · Past); Immune Design Corp (Director · Apr 2, 2019 – Apr 2, 2019 · Past)
Director · May 29, 2019 – Oct 4, 2019 · Past
Lori Kunkel
Other companies: Enliven Therapeutics, Inc. (Director · Since at least Apr 8, 2024); ORIC Pharmaceuticals, Inc. (Director · Since at least Jun 9, 2020); Nurix Therapeutics, Inc. (Director · Jul 23, 2020 – May 19, 2025 · Past); Curis, Inc. (Director · Jan 22, 2018 – Jan 31, 2022 · Past); Loxo Oncology Inc (Director · Nov 2, 2017 – Feb 15, 2019 · Past)
Director · Jun 21, 2018 – Oct 4, 2019 · Past
Paul Schimmel
Other companies: aTyr Pharma, Inc. (Director · Since at least May 6, 2015); Alnylam Pharmaceuticals, Inc. (Co-founder and member of the Board of Directors · Since at least Jan 31, 2006); Sirtris Pharmaceuticals Inc (Director · May 22, 2007 – Nov 30, 2007 · Past); Repligen Corporation (Director · Aug 11, 2006 – Jun 14, 2007 · Past); Alkermes plc (Director · Mar 2, 2006 – Jun 15, 2007 · Past)
Director · Apr 12, 2017 – Oct 4, 2019 · Past
Mark Foletta
Other companies: Enanta Pharmaceuticals, Inc. (Director · Since at least Jun 29, 2020); AMN Healthcare Services Inc (Director · Since at least Nov 27, 2017); DexCom, Inc. (Director · Since at least Nov 27, 2017); Regulus Therapeutics Inc (Director · Dec 4, 2017 – Dec 4, 2017 · Past)
EVP & Chief Financial Officer · Dec 8, 2017 – Oct 4, 2019 · Past
Fairooz Kabbinavar
Other companies: Cardiff Oncology, Inc. (Chief Medical Officer · Jan 30, 2023 – Mar 11, 2025 · Past)
SVP Clinical Development · Apr 15, 2019 – Oct 4, 2019 · Past
Douglas JollyEVP, Research & Pharm Devel · Apr 12, 2017 – Oct 4, 2019 · Past
Martin J DuvallChief Executive Officer, Director · Dec 8, 2017 – Oct 4, 2019 · Past

Open People

Log in to ask 6ix AI your own questions about Tocagen Inc.